Haleon plc (ETR:H6D0)
4.784
+0.039 (0.82%)
At close: May 9, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Oral Health | 3.31B |
Log In |
Log In |
Log In |
Log In |
Oral Health Growth | 5.61% |
Log In |
Log In |
Log In |
Log In |
Vitamins, Minerals and Supplement | 1.70B |
Log In |
Log In |
Log In |
Log In |
Vitamins, Minerals and Supplement Growth | 3.41% |
Log In |
Log In |
Log In |
Log In |
Pain Relief | 2.56B |
Log In |
Log In |
Log In |
Log In |
Pain Relief Growth | -3.32% |
Log In |
Log In |
Log In |
Log In |
Respiratory Health | 1.68B |
Log In |
Log In |
Log In |
Log In |
Respiratory Health Growth | -3.40% |
Log In |
Log In |
Log In |
Log In |
Digestive Health and Other | 1.98B |
Log In |
Log In |
Log In |
Log In |
Digestive Health and Other Growth | -7.20% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
North America | 4.04B |
Log In |
Log In |
Log In |
Log In |
North America Growth | -3.65% |
Log In |
Log In |
Log In |
Log In |
EMEA & LatAm | 4.63B |
Log In |
Log In |
Log In |
Log In |
EMEA & LatAm Growth | 1.89% |
Log In |
Log In |
Log In |
Log In |
APAC | 2.56B |
Log In |
Log In |
Log In |
Log In |
APAC Growth | -0.08% |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
North America Adjusted Operating Profit | 1.00B |
Log In |
Log In |
Log In |
Log In |
North America Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In |
EMEA & LatAm Adjusted Operating Profit | 1.05B |
Log In |
Log In |
Log In |
Log In |
EMEA & LatAm Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In |
APAC Adjusted Operating Profit | 539.00M |
Log In |
Log In |
Log In |
Log In |
APAC Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In |
Corporate Adjusted Operating Profit | -93.00M |
Log In |
Log In |
Log In |
Log In |
Corporate Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In |
Organic Revenue Growth | 5.00% |
Log In |
Log In |
Log In |
Log In |
Sales Growth due to Price | 3.70% |
Log In |
Log In |
Log In |
Log In |
Sales Growth due to Volume/Mix | 1.30% |
Log In |
Log In |
Log In |
Log In |